2nd Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety, prescription drug abuse, value of prescription drugs

LobbyistCovered position, as disclosed
TRACY SPICER —

Medicare/Medicaid MMM

Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169); S. 150, Affordable Prescriptions for Patients Act of 2023

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE

Bills named: S. 150 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.